Secondary Prevention of Myocardial Infarction in People Living With HIV Infection

Secondary Prevention of Myocardial Infarction in People Living With HIV Infection

Bibliographic Details
Main Authors:	Sebhat Erqou, Maria C. Rodriguez‐Barradas
Format:	Article
Language:	English
Published:	Wiley 2020-09-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials heart failure HIV infection myocardial infarction prevention
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.120.018140

Similar Items

Assessment of clopidogrel on the left ventricular ejection fraction in acute myocardial infarction
by: Pejman Khosravi, et al.
Published: (2010-01-01)

Myocardial infarction in people living with HIV/AIDS
by: Shailesh Singh, et al.
Published: (2020-01-01)

2020 expert consensus on the prevention and treatment of heart failure after myocardial infarction
Published: (2021-01-01)

Cardiovascular prevention and rehabilitation in the elderly: evidence for cardiac rehabilitation after myocardial infarction or chronic heart failure
by: Francesco Fattirolli, et al.
Published: (2016-06-01)

Serum lipidomics reveals phosphatidylethanolamine and phosphatidylcholine disorders in patients with myocardial infarction and post-myocardial infarction-heart failure
by: Jidong Rong, et al.
Published: (2023-05-01)

PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: E. V. Horolets, et al.
Published: (2016-01-01)

Post - Myocardial infarction heart failure: present scenario and challenges ahead
by: Pankaj V. Jariwala
Published: (2020-10-01)

Lung ultrasound in acute myocardial infarction. Updating Killip & Kimball
by: Jorge I. Parras, et al.
Published: (2021-01-01)

Effects of Hospital Base "Discharge Teaching" on Self-Care among Post Myocardial Infarction of Follow-Up Patients at Tertiary Care Hospital
by: Ranjeeta Bai, et al.
Published: (2022-03-01)

Comorbidity in acute heart failure complicating myocardial infarction
by: M. V. Zykov, et al.
Published: (2020-08-01)

Persistent Inflammation, Stem Cell–Induced Systemic Anti‐Inflammatory Effects, and Need for Repeated Stem Cell Injections: Critical Concepts Influencing Optimal Stem Cell Strategies for Treating Acute Myocardial Infarction and Heart Failure
by: Stephen E. Epstein, et al.
Published: (2018-02-01)

Thioredoxin 2 protects mice against experimental myocardial infarction
by: Tania Medali, et al.
Published: (2024-04-01)

Short-term and long-term prognosis in patients with Q-myocardial infarction complicated by acute heart failure with hyperglycemia
by: V. D. Syvolap, et al.
Published: (2019-10-01)

So Much to Say on the Best of What's Around Regarding Sodium‐Glucose Cotransporter‐2 Inhibitors in Acute Myocardial Infarction
by: Jairo T. Nunes, et al.
Published: (2023-07-01)

Case 3/2017 - A 47-Year-Old Female with Refractory Heart Failure and Embolic Acute Myocardial Infarction
by: João Gabriel Batista Lage, et al.

Long-Term Pharmacological Management of Reduced Ejection Fraction Following Acute Myocardial Infarction: Current Status and Future Prospects
by: Abel AAI, et al.
Published: (2021-11-01)

Stroke Risk Period After Acute Myocardial Infarction Revised
by: Jukka Putaala, et al.
Published: (2018-11-01)

The Intersection of Type 2 Myocardial Infarction and Heart Failure
by: Cian P. McCarthy, et al.
Published: (2021-09-01)

Secondary Prevention after Myocardial Infarction: What to Do and Where to Do It
by: Vladimír Tuka, et al.
Published: (2022-06-01)

Potential traditional Chinese medicines with anti-inflammation in the prevention of heart failure following myocardial infarction
by: Zhen Zhang, et al.
Published: (2023-03-01)

A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure
by: Pema Raj, et al.
Published: (2021-10-01)

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure
by: Stefano Toldo, PhD, et al.
Published: (2017-08-01)

The Influence of SARS-CoV-2 Infection on Acute Myocardial Infarction Outcomes
by: Eugeniusz Hrycek, et al.
Published: (2023-09-01)

Renal denervation improves cardiac function by attenuating myocardiocyte apoptosis in dogs after myocardial infarction
by: Li Wang, et al.
Published: (2018-05-01)

Secondary prevention and rehabilitation of patients with the myocardial infarction in policlinic
by: A. D. Kuimov, et al.
Published: (2014-12-01)

Atrial Fibrillation in Patients after Myocardial Infarction: Association with Changes in Heart Structure, Heart Failure and Age
by: Yagensky A., et al.
Published: (2014-12-01)

Hemodynamic changes and autonomic nervous system after acute myocardial infarction in rats submitted to left coronary artery ligation
by: Daniela Meirelles Nascimento, et al.
Published: (2018-07-01)

Bilirubin Is Inversely Associated With Cardiovascular Disease Among HIV‐Positive and HIV‐Negative Individuals in VACS (Veterans Aging Cohort Study)
by: Vincent C. Marconi, et al.
Published: (2018-05-01)

Serum zinc concentration in patients with myocardial infarction: a retrospective study
by: Atsushi Tanita, et al.
Published: (2024-02-01)

Meta-Analysis of Placebo-Controlled Trials of Levosimendan in Acute Myocardial Infarction
by: Gabriele Tumminello, et al.
Published: (2021-10-01)

Reducing Low‐Density Lipoprotein Cholesterol After Myocardial Infarction in Older Individuals, Levels Versus Change: Can Observational Studies Answer the Questions?
by: Lewis H. Kuller
Published: (2018-05-01)

Timing of heart failure development and clinical outcomes in patients with acute myocardial infarction
by: Hyung Yoon Kim, et al.
Published: (2023-06-01)

Role of macrophages in cardiorenal syndrome development in patients with myocardial infarction
by: M. A. Kercheva, et al.
Published: (2021-05-01)

Questions of secondary prevention and rehabilitation of patients with myocardial infarction at different stages
by: A. D Kuimov, et al.
Published: (2015-06-01)

PLACE OF VOLUMETRIC LOAD IN ASSESSMENT OF DIASTOLIC RESERVE OF THE LEFT VENTRICLE AND IN PREDICTION OF HEART FAILURE DEVELOPMENT FOR MYOCARDIAL INFARCTION PATIENTS
by: M. T. Beyshenkulov, et al.
Published: (2016-08-01)

Statin drugs mitigate cellular inflammatory response after ST elevation myocardial infarction, but do not affect in-hospital mortality
by: Leili Pourafkari, et al.
Published: (2016-03-01)

Prognostic value of GDF levels 15 and NTproBNP and echocardiographic parameters in patients with heart failure with preserved ejection fraction, after myocardial infarction on the background of hypertension according to the three-year observation
by: V. D. Syvolap, et al.
Published: (2015-10-01)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
by: Ming-Yun Ho, et al.
Published: (2021-08-01)

Rats with high left ventricular end-diastolic pressure can be identified by Doppler echocardiography one week after myocardial infarction
by: R.M. Saraiva, et al.
Published: (2007-11-01)

OPTIMIZATION OF THE TREATMENT OF ELDERLY PATIENTS WITH MYOCARDIAL INFARCTION BY REVASCULARIZATION IN COMBINATION WITH INOTROPIC STIMULATION AND MYOCARDIAL UNLOADING
by: D. S. Krivonosov, et al.
Published: (2016-01-01)